Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Deleveraging Programme Update

20 Jun 2024 07:00

RNS Number : 1271T
Phoenix Group Holdings PLC
20 June 2024
 

 

Phoenix Group Holdings plc

LEI: 2138001P49OLAEU33T68

 

Phoenix Group deleveraging programme update

 

The Board of Phoenix Group Holdings plc ("Phoenix Group" or "the Group") is pleased to announce the completion of the initial phase of its deleveraging programme, comprising a debt redemption and refinancing exercise.

This is in support of the Group's stated deleveraging programme, where it intends to repay at least £500 million of debt and is targeting a Solvency II leverage ratio of c.30% by the end of 2026.

On 3 May 2024 the Group announced that it would fully redeem its £250 million Tier 2 notes due 2029 on their first call date of 13 June 2024, which have now been fully repaid.

The Group has also prudently chosen to re-finance $500 million of its outstanding Restricted Tier 1 ("RT1") notes callable in early 2025 through a tender exercise, and successfully issued $500 million of new RT1 notes at a $ coupon of 8.5%.

The Group has therefore reduced its outstanding debt by £250 million, with its annual debt interest costs broadly unchanged after this redemption and refinancing exercise. As a result, the Group maintains its strong cash interest cover of c.6 times.


Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs and Investor Relations, Phoenix Group

+44 (0)20 4559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 4559 3145

Media:

Douglas Campbell, Teneo

+44 (0)7753 136 628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 4559 3031


Legal Disclaimers

This announcement in relation to Phoenix Group Holdings plc and its subsidiaries (the 'Group') contains, and the Group may make other statements (verbal or otherwise) containing, forward-looking statements and other financial and/or statistical data about the Group's current plans, goals, ambitions, outlook, guidance and expectations relating to future financial condition, performance, results, strategy and/or objectives.

Statements containing the words: 'believes', 'intends', 'will', 'may', 'should', 'expects', 'plans', 'aims', 'seeks', 'targets', 'continues' and 'anticipates' or other words of similar meaning are forward looking. Such forward-looking statements and other financial and/or statistical data involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. For example, certain insurance risk disclosures are dependent on the Group's choices about assumptions and models, which by their nature are estimates. As such, actual future gains and losses could differ materially from those that the Group has estimated.

Other factors which could cause actual results to differ materially from those estimated by forward-looking statements include, but are not limited to: domestic and global economic, political, social, environmental and business conditions; asset prices; market related risks such as fluctuations in investment yields, interest rates and exchange rates, the potential for a sustained low-interest rate or high-interest rate, environment, and the performance of financial or credit markets generally; the policies and actions of governmental and/or regulatory authorities, including, for example, initiatives related to the financial crisis, the COVID-19 pandemic, climate change and the effect of the UK's version of the "Solvency II" regulations on the Group's capital maintenance requirements; the impact of changing inflation rates (including high inflation) and/or deflation; the medium and long-term political, legal, social and economic effects of the COVID-19 pandemic and the UK's exit from the European Union; the direct and indirect consequences of the European and global macroeconomic conditions of the Russia-Ukraine War and related or other geopolitical conflicts; information technology or data security breaches (including the Group being subject to cyberattacks); the development of standards and interpretations including evolving practices in ESG and climate reporting with regard to the interpretation and application of accounting; the limitation of climate scenario analysis and the models that analyse them; lack of transparency and comparability of climate-related forward-looking methodologies; climate change and a transition to a low-carbon economy (including the risk that the Group may not achieve its targets); market competition; changes in assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, gender pricing and lapse rates); the timing, impact and other uncertainties of proposed or future acquisitions, disposals or combinations within relevant industries; risks associated with arrangements with third parties; inability of reinsurers to meet obligations or unavailability of reinsurance coverage; the impact of changes in capital, and implementing changes in IFRS 17 or any other regulatory solvency and/or accounting standards, and tax and other legislation and regulations in the jurisdictions in which members of the Group operate.

As a result, the Group's actual future financial condition, performance and results may differ materially from the plans, goals, ambitions, outlook, guidance and expectations set out in the forward-looking statements and other financial and/or statistical data within this announcement. The Group undertakes no obligation to update any of the forward-looking statements or data contained within this announcement or any other forward-looking statements or data it may make or publish. Nothing in this announcement constitutes, nor should it be construed as, a profit forecast or estimate.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction. The securities referred to above have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States and may not be offered or sold to U.S. persons or to persons within the United States, except pursuant to an exemption from the Securities Act.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAXKNFEFLEFA
Date   Source Headline
3rd Sep 20188:00 amRNSRe-admission of Phoenix Group Holdings
31st Aug 20185:45 pmRNSCompletion of Sale
31st Aug 20185:45 pmRNSCompletion of Standard Life Assurance Acquisition
31st Aug 20189:30 amRNSTotal Voting Rights
24th Aug 20184:15 pmRNSPublication of Suppl.Prospcts
23rd Aug 20184:46 pmRNSPublication of Suppl.Prospcts
23rd Aug 20187:00 amRNSHalf-year Report
10th Aug 20184:15 pmRNSHolding(s) in Company
10th Aug 20183:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSChairman Appointment
31st Jul 20184:45 pmRNSTotal Voting Rights
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSWarrant Redemption Notice
13th Jul 20183:40 pmRNSDirector/PDMR Shareholding
13th Jul 201811:00 amRNSHolding(s) in Company
12th Jul 201812:30 pmRNSTotal Voting Rights
11th Jul 20184:45 pmRNSTotal Voting Rights
10th Jul 201812:40 pmRNSResults of Rump Placing
10th Jul 20189:15 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSResults of Rights Issue
9th Jul 20182:45 pmRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
4th Jul 201812:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20182:00 pmRNSHolding(s) in Company
2nd Jul 201812:45 pmRNSDirector/PDMR Shareholding
29th Jun 201811:45 amRNSTotal Voting Rights
28th Jun 20183:00 pmRNSHolding(s) in Company
28th Jun 20183:00 pmRNSDirector/PDMR Shareholding
26th Jun 20188:06 amRNSAdmission of Nil Paid Rights
25th Jun 20181:45 pmRNSResults of General Meeting
25th Jun 20187:03 amRNSDirectorate Change
25th Jun 20187:00 amRNSBoard Changes
8th Jun 201810:15 amRNSDirector Declaration
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
6th Jun 20182:45 pmRNSHolding(s) in Company
31st May 20183:00 pmRNSTotal Voting Rights
30th May 201812:00 pmRNSPublication of Prospectus Circular & Notice of EGM
30th May 20187:00 amRNSLaunch of £950 million rights issue
22nd May 20189:59 amRNSPost Stabilisation Notice
21st May 201811:00 amRNSBlock Listing Application
11th May 20184:00 pmRNSDirector/PDMR Shareholding
10th May 20189:30 amRNSDirector Declaration
9th May 20182:46 pmRNSDirector/PDMR Shareholding
9th May 20182:45 pmRNSDirector/PDMR Shareholding
3rd May 201812:30 pmRNSUpdate on Standard Life Assurance Transaction
3rd May 201812:30 pmRNSUpdate on proposed transaction
2nd May 20183:30 pmRNSResult of AGM
2nd May 201810:19 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.